Sequencing: Page 3

ACLA warns proposed Medicare criteria will ‘impede’ access to genetic oncology testing
By Nick Paul Taylor
The American Clinical Laboratory Association (ACLA) has warned that draft Medicare coverage criteria “will impede patient access to appropriate genetic testing for oncology.”
October 6, 2023
Lab Test Tube Dna Blood Social
FDA authorizes Invitae hereditary cancer panel
By Nick Paul Taylor
The U.S. Food and Drug Administration (FDA) has granted de novo authorization to an Invitae panel that tests for hundreds of genetic variants that indicate whether a person has a higher risk of developing certain cancers.
October 5, 2023
Dna Cancer Cell Social
Consumer genetic testing may misrepresent breast cancer risk: Study
By Matt Limb
Women are being told they are at high risk of breast cancer from consumer genetic test results which do not take family history into account, say researchers.
September 21, 2023
Breast Cancer3 Social
Rome Therapeutics raises $72M in series B financing
By Matt Limb
Biotech company Rome Therapeutics has raised a further $72 million in financing to develop medicines for autoimmune diseases and continue its exploration of the “dark genome.”
September 20, 2023
Dna Genome Gene Targeted Social
Researchers develop signature for scoring thyroid cancers
By LabPulse.com staff writers
A team led by researchers at Vanderbilt University Medical Center has developed a signature for thyroid cancer aggressiveness that incorporates immune and other microenvironment features through multiomic analyses.
September 20, 2023
Thyroid Social
Broken String Biosciences raises $15M in series A financing round
By LabPulse.com staff writers
Broken String Biosciences has closed a $15 million series A financing round.
September 19, 2023
Dna Sequence Shadow Social
Myriad Genetics, Memorial Sloan Kettering collaborate on MRD testing for breast cancer
By LabPulse.com staff writers
Myriad Genetics is collaborating with Memorial Sloan Kettering Cancer Center to study the use of Myriad's minimal residual disease testing platform in predicting breast cancer treatment response.
September 18, 2023
Breast Mammo Social
Identification of hundreds of blood pressure genes lays foundation for hypertension drugs
By Nick Paul Taylor
Researchers have found hundreds of genes that may affect blood pressure, setting the stage for further studies that could inform the development of new treatments for hypertension.
September 12, 2023
Cell Gene Therapy Dna Social
Illumina names new CEO
By LabPulse.com staff writers
Illumina has appointed Agilent Technologies’ Senior Vice President Jacob Thaysen as CEO, effective September 25.
September 8, 2023
Businessman Applaud Social
Actome outlines sequencing expansion plans as EU funding kicks in
By Nick Paul Taylor
Actome has outlined how funding from the European Innovation Council (EIC) will support work to adapt its technology to enable the measurement of “50 to 100 antibodies at the same time in a single cell.”
September 7, 2023
Single Cell Analysis Social
Grail partners with LGBTQ+ group on study of cancer detection blood test
By Nick Paul Taylor
Grail has partnered with the Whitman-Walker Institute and the Cancer Support Community to assess the feasibility of using its multicancer early detection (MCED) Galleri blood test in a real-world setting.
September 1, 2023
Cancer Cell Microenvironment Social
Oxford Nanopore, IQVIA form nanopore sequencing partnership
By Matt Limb
Oxford Nanopore Technologies and IQVIA have struck a partnership to broaden access to nanopore sequencing technology, saying it will boost genomics research and patient care.
August 31, 2023
Business Handshake Intelligence Social
Previous Page
Page 3 of 49
Next Page